Summary
563.51 -1.02(-0.18%)05/20/2024
Mckesson Corporation (MCK)
Mckesson Corporation (MCK)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 2.46 | 1.74 | 2.68 | 5.62 | 19.32 | 48.72 | 352.15 | 4,196.82 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 546.56 | |
| Open | 533.55 | |
| High | 546.62 | |
| Low | 533.52 | |
| Volume | 815,828 | |
| Change | 13.15 | |
| Change % | 2.46 | |
| Avg Volume (20 Days) | 666,918 | |
| Volume/Avg Volume (20 Days) Ratio | 1.22 | |
| 52 Week Range | 364.09 - 546.62 | |
| Price vs 52 Week High | -0.01% | |
| Price vs 52 Week Low | 50.12% | |
| Range | 2.44 | |
| Gap Up/Down | -1.08 | |
Fundamentals | ||
| Market Capitalization (Mln) | 73,380 | |
| EBIDTA | 4,460,000,256 | |
| PE Ratio | 24.9960 | |
| PEG Ratio | 4.9621 | |
| WallStreet Target Price | 595.69 | |
| Book Value | -15.1620 | |
| Earnings Per Share | 22.4000 | |
| EPS Estimate Current Quarter | 6.3400 | |
| EPS Estimate Next Quarter | 7.1500 | |
| EPS Estimate Current Year | 27.5900 | |
| EPS Estimate Next Year | 31.0200 | |
| Diluted EPS (TTM) | 22.4000 | |
| Revenues | ||
| Profit Marging | 0.0097 | |
| Operating Marging (TTM) | 0.0151 | |
| Return on asset (TTM) | 0.0378 | |
| Return on equity (TTM) | 0.0000 | |
| Revenue TTM | 308,950,990,848 | |
| Revenue per share TTM | 2,319.4520 | |
| Quarterly Revenue Growth (YOY) | 0.1080 | |
| Quarterly Earnings Growth (YOY) | 0.0560 | |
| Gross Profit (TTM) | 12,358,000,000 | |
| Dividends | ||
| Dividend Share | 2.4000 | |
| Dividend Yield | 0.0044 | |
| Valuations | ||
| Trailing PE | 24.9960 | |
| Forward PE | 16.8634 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 5.0435 | |
| Revenue Enterprise Value | 0.2466 | |
| EBITDA Enterprise Value | 16.7539 | |
| Shares | ||
| Shares Outstanding | 129,986,000 | |
| Shares Float | 129,728,143 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.02 | |
| Insider (%) | 0.06 | |
| Institutions (%) | 89.27 | |
05/17 10:56 EST - zacks.com
Here's Why McKesson (MCK) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why McKesson (MCK) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
05/08 13:46 EST - zacks.com
McKesson (MCK) Q4 Earnings Miss Estimates, Revenues Up Y/Y
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
McKesson (MCK) Q4 Earnings Miss Estimates, Revenues Up Y/Y
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
05/07 20:01 EST - seekingalpha.com
McKesson Corporation (MCK) Q4 2024 Earnings Call Transcript
McKesson Corporation (NYSE:MCK ) Q4 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Rachel Rodriguez - VP of Investor Relations Brian Tyler - Chief Executive Officer Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Allen Lutz - Bank of America Merrill Lynch Lisa Gill - JPMorgan Michael Cherny - Leerink Partners Charles Rhyee - TD Cowen Eric Percher - Nephron Research Stephanie Davis - Barclays Elizabeth Anderson - Evercore ISI Daniel Grosslight - Citi Erin Wright - Morgan Stanley Stephen Baxter - Wells Fargo Operator Please stand by. Welcome to McKesson's Fourth Quarter Fiscal 2024 Earnings Conference Call.
McKesson Corporation (MCK) Q4 2024 Earnings Call Transcript
McKesson Corporation (NYSE:MCK ) Q4 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Rachel Rodriguez - VP of Investor Relations Brian Tyler - Chief Executive Officer Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Allen Lutz - Bank of America Merrill Lynch Lisa Gill - JPMorgan Michael Cherny - Leerink Partners Charles Rhyee - TD Cowen Eric Percher - Nephron Research Stephanie Davis - Barclays Elizabeth Anderson - Evercore ISI Daniel Grosslight - Citi Erin Wright - Morgan Stanley Stephen Baxter - Wells Fargo Operator Please stand by. Welcome to McKesson's Fourth Quarter Fiscal 2024 Earnings Conference Call.
05/07 19:01 EST - zacks.com
McKesson (MCK) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
McKesson (MCK) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
05/07 18:59 EST - reuters.com
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged sales in its U.S. pharmaceutical segment.
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged sales in its U.S. pharmaceutical segment.
05/07 18:20 EST - zacks.com
McKesson (MCK) Q4 Earnings and Revenues Lag Estimates
McKesson (MCK) came out with quarterly earnings of $6.18 per share, missing the Zacks Consensus Estimate of $6.34 per share. This compares to earnings of $7.19 per share a year ago.
McKesson (MCK) Q4 Earnings and Revenues Lag Estimates
McKesson (MCK) came out with quarterly earnings of $6.18 per share, missing the Zacks Consensus Estimate of $6.34 per share. This compares to earnings of $7.19 per share a year ago.
05/07 16:10 EST - businesswire.com
McKesson Corporation Reports Fiscal 2024 Fourth Quarter and Full Year Results
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Tuesday, May 7th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and arch.
McKesson Corporation Reports Fiscal 2024 Fourth Quarter and Full Year Results
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Tuesday, May 7th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and arch.
05/07 10:46 EST - zacks.com
Here's Why McKesson (MCK) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why McKesson (MCK) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
05/02 10:21 EST - zacks.com
Seeking Clues to McKesson (MCK) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for McKesson (MCK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
Seeking Clues to McKesson (MCK) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for McKesson (MCK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
04/30 11:06 EST - zacks.com
Earnings Preview: McKesson (MCK) Q4 Earnings Expected to Decline
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: McKesson (MCK) Q4 Earnings Expected to Decline
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
04/26 19:16 EST - zacks.com
McKesson (MCK) Rises But Trails Market: What Investors Should Know
In the closing of the recent trading day, McKesson (MCK) stood at $543.30, denoting a +0.62% change from the preceding trading day.
McKesson (MCK) Rises But Trails Market: What Investors Should Know
In the closing of the recent trading day, McKesson (MCK) stood at $543.30, denoting a +0.62% change from the preceding trading day.
04/26 10:55 EST - zacks.com
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
04/25 14:10 EST - barrons.com
9 Stocks That Thrive When Interest Rates Are Higher
Though economic stress could be on the way, a few groups of stocks can benefit.
9 Stocks That Thrive When Interest Rates Are Higher
Though economic stress could be on the way, a few groups of stocks can benefit.
04/22 16:02 EST - investorplace.com
The Top 3 Healthcare Stocks to Buy in April 2024
Healthcare stocks, especially industry leaders that offer a wide range of products and services, can be an investor's best friend due to the growing need for increased development of healthcare products and services. These stocks tend to provide investors with a substantial return on their investment.
The Top 3 Healthcare Stocks to Buy in April 2024
Healthcare stocks, especially industry leaders that offer a wide range of products and services, can be an investor's best friend due to the growing need for increased development of healthcare products and services. These stocks tend to provide investors with a substantial return on their investment.
04/19 10:40 EST - zacks.com
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
04/02 09:00 EST - businesswire.com
McKesson Launches Project Oasis to Address Pharmacy Deserts in Underserved Communities
IRVING, Texas--(BUSINESS WIRE)--McKesson launches Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities.
McKesson Launches Project Oasis to Address Pharmacy Deserts in Underserved Communities
IRVING, Texas--(BUSINESS WIRE)--McKesson launches Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities.
03/28 12:46 EST - zacks.com
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
03/27 16:10 EST - businesswire.com
McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations website at http://investor.mckesson.com, along with the company's earnings release, financial tables and s.
McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live webcast will be available on McKesson's Investor Relations website at http://investor.mckesson.com, along with the company's earnings release, financial tables and s.
03/26 10:52 EST - reuters.com
Rite Aid reaches bankruptcy settlement with lenders, DOJ, McKesson
Pharmacy chain Rite Aid has reached a settlement with its lenders, the U.S. Department of Justice, and drug supplier McKesson Corp , clearing a path for Rite Aid to complete its bankruptcy case by late April, a company lawyer said Tuesday.
Rite Aid reaches bankruptcy settlement with lenders, DOJ, McKesson
Pharmacy chain Rite Aid has reached a settlement with its lenders, the U.S. Department of Justice, and drug supplier McKesson Corp , clearing a path for Rite Aid to complete its bankruptcy case by late April, a company lawyer said Tuesday.